We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $625M
1-Year Est. Return 39.69%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.88%
AUM
$329M
AUM Growth
+$8.73M
Cap. Flow
-$8.73M
Cap. Flow %
-2.65%
Top 10 Hldgs %
31.77%
Holding
193
New
9
Increased
45
Reduced
50
Closed
9

Sector Composition

Rank Sector Weight
1 Technology 21.36%
2 Consumer Discretionary 11.91%
3 Healthcare 10.95%
4 Communication Services 9.27%
5 Consumer Staples 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RDS.A
151
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$347K 0.11%
8,597
TDOC icon
152
Teladoc Health
TDOC
$1.58B
$342K 0.1%
2,054
+66
+3% +$10.7K
YUMC icon
153
Yum China
YUMC
$14.9B
$324K 0.1%
4,890
IUSV icon
154
iShares Core S&P US Value ETF
IUSV
$27.2B
$309K 0.09%
4,291
IEI icon
155
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$303K 0.09%
2,322
SHV icon
156
iShares 0-1 Year Treasury Bond ETF
SHV
$20.7B
$284K 0.09%
2,573
WPM icon
157
Wheaton Precious Metals
WPM
$50.6B
$284K 0.09%
6,450
IJH icon
158
iShares Core S&P Mid-Cap ETF
IJH
$123B
$282K 0.09%
5,250
VCSH icon
159
Vanguard Short-Term Corporate Bond ETF
VCSH
$44.7B
$274K 0.08%
+3,312
New +$274K
MRK icon
160
Merck
MRK
$324B
$271K 0.08%
3,490
-6,124
-64% -$456K
XLC icon
161
State Street Communication Services Select Sector SPDR ETF
XLC
$21.9B
$268K 0.08%
3,312
+199
+6% +$15.5K
PLTR icon
162
Palantir
PLTR
$295B
$264K 0.08%
+10,000
New +$231K
TEVA icon
163
Teva Pharmaceuticals
TEVA
$35.9B
$258K 0.08%
26,100
MA icon
164
Mastercard
MA
$477B
$252K 0.08%
690
SCHM icon
165
Schwab US Mid-Cap ETF
SCHM
$14.6B
$250K 0.08%
9,600
+603
+7% +$15.6K
EWGS
166
DELISTED
iShares MSCI Germany Small-Cap ETF
EWGS
$249K 0.08%
3,062
+186
+6% +$15.3K
SPSB icon
167
State Street SPDR Portfolio Short Term Corporate Bond ETF
SPSB
$10.4B
$248K 0.08%
7,935
BDX icon
168
Becton Dickinson
BDX
$43.1B
$243K 0.07%
1,025
SPTS icon
169
State Street SPDR Portfolio Short Term Treasury ETF
SPTS
$6.07B
$243K 0.07%
7,942
MMM icon
170
3M
MMM
$89B
$239K 0.07%
1,441
XLV icon
171
State Street Health Care Select Sector SPDR ETF
XLV
$42.1B
$239K 0.07%
1,897
+126
+7% +$15.4K
KMB icon
172
Kimberly-Clark
KMB
$36.4B
$238K 0.07%
1,780
MO icon
173
Altria Group
MO
$122B
$233K 0.07%
4,890
ECL icon
174
Ecolab
ECL
$75.6B
$227K 0.07%
1,100
VGK icon
175
Vanguard FTSE Europe ETF
VGK
$30B
$225K 0.07%
3,350

Similar funds

Bellecapital's Q2 2021 Portfolio in Review

As of Q2 2021, Bellecapital held 193 positions worth $329M, up 2.7% from $320M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Bellecapital's Q2 2021 filing shows 9 new, 45 increased, 50 reduced and 9 closed positions. Its largest new stake was Otis Worldwide: 8,236 shares worth $673K. The largest sale was Alphabet (Google) Class A, an estimated $3.03M.

By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 21% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Bellecapital's largest Q2 2021 buy was Otis Worldwide: 8,236 shares worth $673K.
  • Bellecapital added most to PIMCO 0-5 Year High Yield Corporate Bond Index Exchange-Traded Fund in Q2 2021, an estimated $2.03M increase.
  • Bellecapital's biggest Q2 2021 reduction was Alphabet (Google) Class A, cutting an estimated $3.03M.
  • Bellecapital fully exited GW Pharmaceuticals Plc American Depositary Shares in Q2 2021, selling an estimated $477K.
  • Bellecapital's ten largest holdings make up 32% of its $329M portfolio in Q2 2021.
  • Bellecapital opened 9 new positions and closed 9 in Q2 2021.
  • Bellecapital's portfolio value rose 2.7% quarter-over-quarter to $329M.

Based on Bellecapital's 13F filing for Q2 2021, filed 28 Jul 2021.